If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

cafead

Administrator
Staff member
  • cafead   Jun 30, 2024 at 10:02: PM
via
  • Altimmune's anti-obesity therapy has a key feature that Wegovy doesn't.
  • That means it could one day steal market share.
  • Altimmune also has enough resources to clarify whether its candidate is a winner.

article source